A Review of Systemic Biologics and Local Immunosuppressive Medications in Uveitis

Uveitis is one of the most common causes of vision loss and blindness worldwide. Local and/or systemic immunosuppression is often required to treat ocular inflammation in noninfectious uveitis. An understanding of safety and efficacy of these medications is required to individualize treatment to each patient to ensure compliance and achieve the best outcome. In this article, we reviewed the effectiveness of systemic biologic response modifiers and local treatments commonly used in the management of patients with noninfectious uveitis.

Automated summary

Uveitis is a common cause of vision loss and blindness worldwide. To ensure personalized treatment, it is important to understand the safety and efficacy of medications used for ocular inflammation. This article reviewed the effectiveness of systemic biologic response modifiers and local treatments commonly used in the management of noninfectious uveitis.